Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (79)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Institution
Department
Faculty Rank
Name
Institution
Why
Robert Rosenfield
University of Chicago
Why?
Melissa Gilliam
University of Chicago
Why?
Tamar S. Polonsky
University of Chicago
Why?
Kevin Hellman
University of Chicago
Why?
Shashwati Pradhan
University of Chicago
Why?
Holly J. Benjamin
University of Chicago
Why?
Arthur L. Herbst
University of Chicago
Why?
Randall Barnes
University of Chicago
Why?
Frank Tu
University of Chicago
Why?
David A. Ehrmann
University of Chicago
Why?
Ayman Al-Hendy
University of Chicago
Why?
Dezheng Huo
University of Chicago
Why?
Callum F. Ross
University of Chicago
Why?
Susan Sam
University of Chicago
Why?
Martha K. McClintock
University of Chicago
Why?
Per Page
15
25
50
100
Page
of 6
Next
Prev
Search Criteria
Menstruation
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions